Building a conducive environment for life science-based entrepreneurship and industry clusters
The global biopharmaceutical industry, with over $70bn in revenues and 700 publicly listed firms posting double-digit growth in North America, Europe, and Asia-Pacific in 2006, represents an attractive and promising high-growth industry of the future. Broad scientific advances and commercial successes have captured the attention and aspirations of policy makers, business people, and investors alike in spurring sector growth. An understanding of the fundamental forces that shape the industry, including the challenges faced by entrepreneurs, as well as many promising industry trends, offer several implications for investors and policy makers. This study explores industry dynamics affecting growth patterns, biotech industry cluster evolution in an era of increasing globalisation, and enabling factors which support entrepreneurship activity, productivity, and sustainability. Governments and investors seeking to create and enhance biotech entrepreneurship face several enabling trends including increasing numbers of science graduates worldwide, accelerating pace of scientific advancement, dominating role of globalisation enabling greater collaboration, democratising forces of the internet, and the relentless competitive pressure to innovate. As such, policy agendas should focus on increasing factor conditions to enhance start-up formation, alliances, and skilled employment, rather than attempt to select specific winners and losers among specific sub-sectors or individual firms.
유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.
원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.
NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.
- 이 논문과 함께 출판된 논문 + 더보기